apalutamide
Showing 26 - 50 of 62
Prostatic Tumors Trial in China (Apalutamide, Placebo, Androgen-deprivation Therapy (ADT))
Recruiting
- Prostatic Neoplasms
- Apalutamide
- +2 more
-
Beijing, China
- +29 more
Aug 15, 2022
High-Risk and Oligometastatic Prostate Cancer Trial (Apalutamide)
Not yet recruiting
- High-Risk and Oligometastatic Prostate Cancer
- Apalutamide
- (no location specified)
Aug 2, 2021
Prostate Cancer Metastatic Trial in Omaha, New York (Apalutamide, Abiraterone acetate, Docetaxel)
Active, not recruiting
- Prostate Cancer Metastatic
- Apalutamide
- +3 more
-
Omaha, Nebraska
- +1 more
Aug 26, 2021
Stage III Prostate Adenocarcinoma AJCC v7, Stage III Prostate Cancer AJCC v7, Stage IV Prostate Adenocarcinoma AJCC v7 Trial in
Completed
- Stage III Prostate Adenocarcinoma AJCC v7
- +3 more
- Abiraterone Acetate
- +5 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Dec 15, 2021
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, PSA Progression Trial in San Francisco (Apalutamide,
Recruiting
- Castration Levels of Testosterone
- +3 more
- Apalutamide
- Stereotactic Body Radiation Therapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Aug 26, 2021
Prostate Cancer Trial in Shatin (Apalutamide, Enzalutamide)
Recruiting
- Prostate Cancer
- Apalutamide
- Enzalutamide
-
Shatin, Hong KongPrince of Wales Hospital
Aug 3, 2021
Prostate Cancer Trial in La Jolla, Boston, New York (Apalutamide, Leuprolide, Prednisone)
Active, not recruiting
- Prostate Cancer
- Apalutamide
- +3 more
-
La Jolla, California
- +3 more
Sep 1, 2021
Prostate Cancer Trial in Brazil (Apalutamide, Abiraterone, ADT)
Completed
- Prostate Cancer
- Apalutamide
- +3 more
-
Salvador, Bahia, Brazil
- +13 more
Jul 5, 2021
Cancer of Prostate Trial in Belgium (Apalutamide, Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial, Goserelin
Recruiting
- Cancer of Prostate
- Apalutamide
- +4 more
-
Aalst, Belgium
- +8 more
Aug 4, 2021
Prostate Cancer Trial in Sao Paulo (Goserelin, Prednisone, Abiraterone)
Unknown status
- Prostate Cancer
- Goserelin
- +3 more
-
Sao Paulo, SP, BrazilInstituto do Cancer do Estado de Sao Paulo
May 14, 2021
Prostate Cancer Trial in France (Apalutamide, Salvage radiotherapy (SRT), Luteinising Hormone Releasing Hormone agonist (LHRHa))
Recruiting
- Prostate Cancer
- Apalutamide
- +2 more
-
Albi, France
- +14 more
Sep 22, 2021
Neoadjuvant Therapy, High Risk Prostate Cancer, Locally Advanced Prostate Cancer Trial in Nanjing (ADT, Abiraterone Acetate,
Recruiting
- Neoadjuvant Therapy
- +3 more
- ADT
- +8 more
-
Nanjing, Jiangsu, ChinaDepartment of Urology, Drum Tower Hospital, Medical School of Na
Aug 12, 2022
Castration Levels of Testosterone, Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma Trial in Houston,
Active, not recruiting
- Castration Levels of Testosterone
- +4 more
- Abiraterone Acetate
- +6 more
-
Houston, Texas
- +2 more
Feb 11, 2022
Advanced Cancer, Solid Tumor Trial in Helsinki, Kuopio, Tampere (Alectinib, Cobimetinib, Vismodegib)
Recruiting
- Advanced Cancer
- Solid Tumor
- Alectinib
- +13 more
-
Helsinki, Uusimaa, Finland
- +2 more
Jun 8, 2022
Newly Diagnosed Oligometastatic Prostate Cancer Trial in Long Beach, West Los Angeles, Richmond (procedure, radiation, drug)
Active, not recruiting
- Newly Diagnosed Oligometastatic Prostate Cancer
- radical prostatectomy
- +4 more
-
Long Beach, California
- +2 more
Mar 16, 2022
Metastatic Castration-sensitive Prostate Cancer Trial in Osaka-sayama (Apalutamide)
Recruiting
- Metastatic Castration-sensitive Prostate Cancer
- Apalutamide
-
Ōsaka-sayama, Osaka, JapanKindai University Hospital
Dec 6, 2020
Prostatic Tumors, Castration-Resistant Trial (Abiraterone, Apalutamide)
Withdrawn
- Prostatic Neoplasms, Castration-Resistant
- Abiraterone
- Apalutamide
- (no location specified)
Nov 15, 2020
Prostate Cancer Trial in Shanghai (drug, procedure, radiation)
Recruiting
- Prostate Cancer
- Leuprolide acetate
- +9 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2022
Prostate Cancer Trial in New York (apalutamide, Everolimus)
Completed
- Prostate Cancer
- apalutamide
- Everolimus
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Jun 29, 2021
Prostate Cancer Trial in Worldwide (Apalutamide, Placebo, Androgen Deprivation Therapy (ADT))
Active, not recruiting
- Prostate Cancer
- Apalutamide
- +2 more
-
Homewood, Alabama
- +228 more
Aug 2, 2022
Prostate Carcinoma, Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Houston (drug, procedure,
Recruiting
- Prostate Carcinoma
- +6 more
- Abiraterone Acetate
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 10, 2022
Prostatic Tumors Trial in Worldwide (Apalutamide, Abiraterone acetate, Prednisone)
Active, not recruiting
- Prostatic Neoplasms
- Apalutamide
- +3 more
-
Phoenix, Arizona
- +183 more
Jan 17, 2023
Prostate Cancer Trial (Radiation Therapy, Apalutamide, Luteinising Hormone Releasing Hormone analog agonist (LHRHa))
Withdrawn
- Prostate Cancer
- Radiation Therapy
- +3 more
- (no location specified)
Aug 13, 2020
Healthy Trial in Merksem (Apalutamide)
Completed
- Healthy
- Apalutamide
-
Merksem, BelgiumClinical Pharmacology Unit
Aug 7, 2020